الفهرس | Only 14 pages are availabe for public view |
Abstract SUMMARY Primary PCI is the preferred reperfusion strategy used in patients with acute STEMI to prevent progression of myocardial necrosis. Besides the advantages of this strategy, there are situations in which myocardial reperfusion is not restored to its optimal level. Angiographic no-reflow phenomenon, a reduced coronary antegrade flow (TIMI flow grade ≤ 2 ) without mechanical obstruction after recanalization, predicts poor LV functional recovery and survival in the early phase of STEMI99. The no-reflow phenomenon is critical and, if not reversed, causes a high rate of morbidity and mortality. It was demonstrated that the no-reflow phenomenon after primary PCI is a strong predictor of death extending to up to 5 years after the acute event in patients with STEMI.179 Although the predisposing factors of the no-reflow phenomenon were investigated, there is little data about clinical and procedural predictors of this phenomenon. The aim of this study was to evaluate the CHA₂DS₂-VASc HSF Score as a predictor of no-reflow in patients who underwent primary percutaneous intervention. The present study was conducted on 100 patients admitted with STEMI and treated with 1ry PCI at cardiovascular medicine department Tanta University Hospitals within 6 months from June 2018 to December 2018. Patients were divided into 2 groups according |